WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Join the Society for Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (40)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Street, V. A.
Right arrow Articles by Tempel, B. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Street, V. A.
Right arrow Articles by Tempel, B. L
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Epilepsy
*Genes and Gene Therapy

 Previous Article  |  Next Article 

Volume 17, Number 2, Issue of January 15, 1997 pp. 635-645
Copyright ©1997 Society for Neuroscience

The Type 1 Inositol 1,4,5-Trisphosphate Receptor Gene Is Altered in the opisthotonos Mouse

Received Aug. 28, 1996; revised Oct. 21, 1996; accepted Nov. 5, 1996.

Valerie A. Street1, Martha M. Bosma1, Vasiliki P. Demas1, Melissa R. Regan2, Doras D. Lin2, Linda C. Robinson1, William S. Agnew2, and Bruce L Tempel1

1 Departments of Otolaryngology and Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195, and Geriatric Research Education and Clinic Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, and 2 Department of Physiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

The opisthotonos (opt) mutation arose spontaneously in a C57BL/Ks-db2J colony and is the only known, naturally occurring allele of opt. This mutant mouse was first identified based on its ataxic and convulsive phenotype. Genetic and molecular data presented here demonstrate that the type 1 inositol 1,4,5-trisphosphate receptor (IP3R1) protein, which serves as an IP3-gated channel to release calcium from intracellular stores, is altered in the opt mutant. A genomic deletion in the IP3R1 gene removes two exons from the IP3R1 mRNA but does not interrupt the translational reading frame. The altered protein is predicted to have lost several modulatory sites and is present at markedly reduced levels in opt homozygotes. Nonetheless, a strong calcium release from intracellular stores can be elicited in cerebellar Purkinje neurons treated with the metabotropic glutamate receptor (mGluR) agonist quisqualate (QA). QA activates Group I mGluRs linked to GTP-binding proteins that stimulate phospholipase C and subsequent production of the intracellular messenger IP3, leading to calcium mobilization via the IP3R1 protein. The calcium response in opt homozygotes shows less attenuation to repeated QA application than in control littermates. These data suggest that the convulsions and ataxia observed in opt mice may be caused by the physiological dysregulation of a functional IP3R1 protein.

Key words: opisthotonos; seizures; genomic deletion; Purkinje neurons; inositol 1,4,5-trisphosphate receptor; metabotropic glutamate receptor; quisqualate; mouse chromosome 6; alternative splicing




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak
Inositol Trisphosphate Receptor Ca2+ Release Channels
Physiol Rev, April 1, 2007; 87(2): 593 - 658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Przyklenk, M. Maynard, and P. Whittaker
First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H2008 - H2012.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Fukatsu, H. Bannai, S. Zhang, H. Nakamura, T. Inoue, and K. Mikoshiba
Lateral Diffusion of Inositol 1,4,5-Trisphosphate Receptor Type 1 Is Regulated by Actin Filaments and 4.1N in Neuronal Dendrites
J. Biol. Chem., November 19, 2004; 279(47): 48976 - 48982.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Hamada, T. Miyata, K. Mayanagi, J. Hirota, and K. Mikoshiba
Two-state Conformational Changes in Inositol 1,4,5-Trisphosphate Receptor Regulated by Calcium
J. Biol. Chem., June 7, 2002; 277(24): 21115 - 21118.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-